Search for Clinical Trial Results
Sialorrhea - 20 Studies Found
Status | Study |
Completed |
Study Name: Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea Condition:
Date: 2012-03-09 Interventions:
|
Completed |
Study Name: Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide Condition: Hypersalivation Date: 2006-09-26 Interventions: Drug: ipratropium bromide 0.03% spray |
Completed |
Study Name: Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) Condition:
Date: 2005-07-27 Interventions:
|
Completed |
Study Name: Metoclopramide as Treatment of Clozapine-induced Hypersalivation Condition: Clozapine-induced Hypersalivation Date: 2014-08-17 Interventions:
|
Completed |
Study Name: Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation Condition: Clozapine-induced Hypersalivation Date: 2007-09-24 Interventions: Drug: Amisulpride, Moclobemide Amisulpride 400 mg/d; Moclobemide 300 mg/d every medication for 2 week ai |
Completed |
Study Name: A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients Condition: Drooling Date: 2007-08-10 Interventions:
|
Completed |
Study Name: Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions Condition:
Interventions: |
Completed |
Study Name: The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia Condition:
|
Completed |
Study Name: FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey Condition:
Date: 2008-05-22 Interventions: Drug: FazaClo (clozapine, USP) ODT |
Completed |
Study Name: Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy Condition:
Date: 2011-11-29 Interventions: Biological: BOTULINUM NEUROTOXIN TYPE-A Botulinum toxin type A / First infiltration: 25U in each salivar |